| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +6,900 | 0.67% | $3.58 | +$24,736 |
| Sells | 5 | -1,028,262 | 99% | $5.46 | -$5,616,740 |
| Net | -3 | -1,021,362 | -99% | -$5,592,004 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| 10X Fund, L.P. | 10%+ Owner | $37,392,283 | -$1,581,991 | -4.1% | 02 Dec 2025 |
| Richard E. Uihlein | Director, 10%+ Owner | $31,526,608 | 16 Jan 2026 | ||
| JOEL LEWIS | President and CEO, Director | $3,213,845 | -$620,536 | -16% | 16 Jan 2026 |
| JAMES C. CZIRR | 10%+ Owner | $1,030,568 | 03 Feb 2025 | ||
| KEVIN D. FREEMAN | Director | $760,936 | +$19,514 | +2.6% | 16 Jan 2026 |
| KARY ELDRED | Director | $269,362 | +$5,222 | +2% | 16 Jan 2026 |
| Jack W. Callicutt | Chief Financial Officer | $143,301 | -$944,397 | -87% | 16 Jan 2026 |
| Pol F. Boudes | Chief Medical Officer | $71,432 | 24 Jan 2024 | ||
| Harold H. Shlevin | Director | $70,597 | -$1,404,943 | -95% | 16 Jan 2026 |
| Khurram Jamil | Chief Medical Officer | $69,600 | -$1,064,873 | -94% | 16 Jan 2026 |
| Richard A. Zordani Jr. | Director | 16 Jan 2026 | |||
| GILBERT S. OMENN | Director | 16 Jan 2026 | |||
| BENJAMIN CARSON SR | Director | 16 Jan 2026 | |||
| GILBERT F. AMELIO | Director | 16 Jan 2026 | |||
| Elissa J. Schwartz | Director | 16 Jan 2026 | |||
| Marc Rubin | Director | 23 Jan 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|